Stonegate Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,714
| Closed | -$1.36M | – | 410 |
|
|
2024
Q2 | $1.36M | Sell |
14,714
-50
| -0.3% | -$4.62K | 0.04% | 143 |
|
|
2024
Q1 | $1.41M | Buy |
14,764
+1,920
| +15% | +$183K | 0.04% | 136 |
|
|
2023
Q4 | $979K | Sell |
12,844
-54
| -0.4% | -$4.12K | 0.03% | 158 |
|
|
2023
Q3 | $894K | Sell |
12,898
-220
| -2% | -$15.2K | 0.03% | 160 |
|
|
2023
Q2 | $1.24M | Hold |
13,118
| – | – | 0.04% | 146 |
|
|
2023
Q1 | $1.09M | Buy |
13,118
+2,392
| +22% | +$198K | 0.04% | 151 |
|
|
2022
Q4 | $800K | Sell |
10,726
-56
| -0.5% | -$4.18K | 0.03% | 162 |
|
|
2022
Q3 | $891K | Sell |
10,782
-3,203
| -23% | -$265K | 0.04% | 137 |
|
|
2022
Q2 | $1.33M | Sell |
13,985
-3,955
| -22% | -$376K | 0.06% | 127 |
|
|
2022
Q1 | $2.11M | Buy |
17,940
+452
| +3% | +$53.2K | 0.07% | 94 |
|
|
2021
Q4 | $2.27M | Buy |
+17,488
| New | +$2.27M | 0.1% | 97 |
|